# Tumor Synthetic Peptide Vaccines Sector

Canonical URL: https://biopharmsignal.com/sector/tumor-synthetic-peptide-vaccines

Tumor Synthetic Peptide Vaccines is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Tumor Synthetic Peptide Vaccines, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Companies currently grouped under Tumor Synthetic Peptide Vaccines: 1

## Recent Sector News

- 2026-07-20 10:00 EST — GLSI — [Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-clinical-updates-on-flamingo-01-99f074c4) — Source: Greenwich LifeSciences
- 2026-07-16 11:30 EST — GLSI — [Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-european-approval-for-combining-both-hla-popula-adf83f60) — Source: Greenwich LifeSciences
- 2026-07-09 10:00 EST — GLSI — [Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-european-approval-for-use-of-commercially-manuf-3adb0b48) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial-open-label-data-published-at-asco-meeting-2026) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-10-q-filing) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-use-of-commercially-manufactured-gp2-in-flamingo-01) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-showing-continued-reduction-in-recurrence-rate-in-the-open-label-arm-of-flamingo-01) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Provides Update on Upcoming AACR Meeting](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-on-upcoming-aacr-meeting) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-addition-of-city-of-hope-to-flamingo-01) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-on-patent-claims-potentially-doubling-gp2-market-potential) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Provides Update on Financing Strategy](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-on-financing-strategy) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Provides Update Regarding Form 10-K Filing](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-regarding-form-10-k-filing) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-acceptance-of-abstract-at-asco-2026) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-10-k-filing) — Source: Greenwich LifeSciences
- 2026-06-25 13:46 EST — GLSI — [Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial-open-label-data-published-at-aacr-meeting-2026) — Source: Greenwich LifeSciences
- 2026-06-01 10:00 EST — GLSI — [Greenwich LifeSciences Provides Update Regarding Form 10-K Filing](https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-provides-update-regarding-form-10-k-filing-5fb4f975) — Source: Greenwich LifeSciences

## Companies

- [GLSI](https://biopharmsignal.com/company/GLSI) — Greenwich LifeSciences